Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate

References

• Atiq F, Saes JL, Punt MC, et al. Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. EClinicalMedicine. 2021;32:100726.
   PubMedGoogle Scholar
• Kulkarni R. Improving care and treatment options for women and girls with bleeding disorders. Eur J Haematol. 2015;95(Suppl 81):2–10.
   PubMedGoogle Scholar
• National Institutes for Health. Consideration of sex as a biological variable in NIH-funded research (additional guidance for NOT-OD-15-102) [cited 2022 May 3]. Available from: https://orwh.od.nih.gov/sites/orwh/files/docs/NOT-OD-15-102%20Guidance.pdf.
   Google Scholar
• James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300.
   PubMed Web of Science ®Google Scholar
• Abe K, Dupervil B, O’Brien SH, et al. Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease. Am J Hematol. 2020;95(1):10–17
   PubMedGoogle Scholar
• James AH. Heavy menstrual bleeding: work-up and management. Hematology Am Soc Hematol Educ Program. 2016;2016(1):236–242.
   PubMedGoogle Scholar
• Kadir RA, Economides DL, Sabin CA, et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351(9101):485–489
   PubMed Web of Science ®Google Scholar
• Munro MG, Critchley HOD, Fraser IS. Figo Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408.
   PubMed Web of Science ®Google Scholar
• Haamid F, Sass AE, Dietrich JE. Heavy menstrual bleeding in adolescents. J Pediatr Adolesc Gynecol. 2017;30(3):335–340.
   PubMedGoogle Scholar
• Rauch A, Valentino LA, Mills K, et al. Big picture initiatives in bleeding disorders. Haemophilia. 2022;28(Suppl 4):53–60
   PubMedGoogle Scholar
• Liu Z, Doan QV, Blumenthal P, et al. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health. 2007;10(3):183–194.
   PubMed Web of Science ®Google Scholar
• Cohen BJ, Gibor Y. Anemia and menstrual blood loss. Obstet Gynecol Surv. 1980;35(10):597–618.
   PubMedGoogle Scholar
• Smith C, Teng F, Branch E, et al. Maternal and perinatal morbidity and mortality associated with anemia in pregnancy. Obstet Gynecol. 2019;134(6):1234–1244
   PubMed Web of Science ®Google Scholar
• Kadir RA, Sabin CA, Pollard D, et al. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia. 1998;4(6):836–841
   PubMedGoogle Scholar
• van Hoorn ES, Houwing ME, Al Arashi W, et al. Patient-reported outcomes in autosomal inherited bleeding disorders: a systematic literature review. Haemophilia. 2022;28(2):197–214
   PubMedGoogle Scholar
• McGrath M, Quint EH, Weyand AC. Depression in adolescents and young adults with heavy menstrual bleeding in a referral clinic setting. Am J Hematol. 2021;96(4):E105–E8.
   PubMedGoogle Scholar
• Weyand AC, Fitzgerald KD, McGrath M, et al. Depression in female adolescents with heavy menstrual bleeding. J Pediatr. 2022;240:171–176.
   PubMed Web of Science ®Google Scholar
• Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6(6):643–648
   PubMed Web of Science ®Google Scholar
• Hews-Girard JC, Galica J, Goldie C, et al. Determining the incidence of postpartum haemorrhage among Ontario women with and without inherited bleeding disorders: a population-based cohort study. Haemophilia. 2022;28(5):832–841
   PubMedGoogle Scholar
• James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost. 2007;5(6):1165–1169.
   PubMed Web of Science ®Google Scholar
• Malec LM, Moore CG, Yabes J, et al. Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database. Haemophilia. 2015;21(5):e442–5
   PubMed Web of Science ®Google Scholar
• Miller CH, Philipp CS, Stein SF, et al. The spectrum of haemostatic characteristics of women with unexplained menorrhagia. Haemophilia. 2011;17(1):e223–9
   PubMed Web of Science ®Google Scholar
• United Kingdom Haemophilia Centre doctors’ organisation and national haemophilia database. UKHCDO Annual Report 2020 & Bleeding Disorder Statistics for 2020/2021. Manchester, Unite Kingdom; 2021 [cited 2022 Jul 25]. Available from: http://www.ukhcdo.org/wp-content/uploads/2021/12/2021-UKHCDO-Annual-Report-2020-21-Data.pdf
   Google Scholar
• Renault NK, Howell RE, Robinson KS, et al. Qualitative assessment of the emotional and behavioural responses of haemophilia A carriers to negative experiences in their medical care. Haemophilia. 2011;17(2):237–245.
   PubMedGoogle Scholar
• van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH. J Thromb Haemost. 2021;19(8):1883–1887
   PubMed Web of Science ®Google Scholar
• Weyand AC, Sidonio RF Jr., Sholzberg M. Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues. Haemophilia. 2022;28(Suppl 4):18–25.
   PubMedGoogle Scholar
• Chaudhury A, Sidonio R Jr., Jain N, et al. Women and girls with haemophilia and bleeding tendencies: outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review. Haemophilia. 2021;27(2):293–304
   PubMedGoogle Scholar
• d’Oiron R, O’Brien S, James AH, et al. Women and girls with haemophilia: lessons learned. Haemophilia. 2021;27 Suppl 3:75–81.
   PubMed Web of Science ®Google Scholar
• Gilbert L, Rollins L, Hilmes M, et al. Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes. Haemophilia. 2014;20(6):e426–9
   PubMed Web of Science ®Google Scholar
• Kirtava A, Drews C, Lally C, et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand’s disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia. 2003;9(3):292–297
   PubMedGoogle Scholar
• Olsson A, Hellgren M, Berntorp E, et al. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B. Blood Coagul Fibrinolysis. 2014;25(5):471–475
   PubMed Web of Science ®Google Scholar
• Puetz J, Cheng D. Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset. Haemophilia. 2021;27(6):1045–1050.
   PubMedGoogle Scholar
• Sidonio RF, Mili FD, Li T, et al. Females with FVIII and FIX deficiency have reduced joint range of motion. Am J Hematol. 2014;89(8):831–836
   PubMedGoogle Scholar
• Arnegard ME, Whitten LA, Hunter C, et al. Sex as a biological variable: a 5-year progress report and call to action. J Womens Health (Larchmt). 2020;29(6):858–864.
   PubMed Web of Science ®Google Scholar
• Dasarathy J, Labrador H. Bone health in women. Prim Care. 2018;45(4):643–657.
   PubMedGoogle Scholar
• Knol HM, Kemperman RF, Kluin-Nelemans HC, et al. Haemostatic variables during normal menstrual cycle. A systematic review. Thromb Haemost. 2012;107(1):22–29
   PubMedGoogle Scholar
• Miller CH, Dilley AB, Drews C, et al. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb Haemost. 2002;87(6):1082–1083
   PubMed Web of Science ®Google Scholar
• Dupuis M, Severin S, Noirrit-Esclassan E, et al. Effects of Estrogens on Platelets and Megakaryocytes. Int J Mol Sci. 2019;20(12):12
   Google Scholar
• James AH, Ragni MV, Picozzi VJ. Bleeding disorders in premenopausal women: (another) public health crisis for hematology?. Hematology Am Soc Hematol Educ Program. 2006;2006(1):474–485.
   Google Scholar
• Oral Contraceptive Hemostasis Study Group . The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study. Contraception. 2003;67(3):173–185.
   PubMedGoogle Scholar
• Connors JM, Middeldorp S. Transgender patients and the role of the coagulation clinician. J Thromb Haemost. 2019;17(11):1790–1797.
   PubMed Web of Science ®Google Scholar
• Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia. 2015;70(Suppl 1):78–86.
   PubMedGoogle Scholar
• Critchley HOD, Babayev E, Bulun SE, et al. Menstruation: science and society. Am J Obstet Gynecol. 2020;223(5):624–664
   PubMed Web of Science ®Google Scholar
• Zia A, Lau M, Journeycake J, et al. Developing a multidisciplinary young women’s blood disorders program: a single-centre approach with guidance for other centres. Haemophilia. 2016;22(2):199–207
   PubMedGoogle Scholar
• Sidonio RF Jr., Zia A, Fallaize D. Potential undiagnosed VWD or other mucocutaneous bleeding disorder cases estimated from private medical insurance claims. J Blood Med. 2020;11:1–11.
   PubMed Web of Science ®Google Scholar
• Arya S, Wilton P, Page D, et al. Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders. PLoS One. 2020;15(2):e0229099
   PubMedGoogle Scholar
• Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost. 2021;5(1):51–54.
   PubMed Web of Science ®Google Scholar
• Lopez K, Norris K, Hardy M, et al. Defining the impact of social drivers on health outcomes for people with inherited bleeding disorders. J Clin Med. 2022;11:15.
   Google Scholar
• Arya S, Wilton P, Page D, et al. “Everything was blood when it comes to me”: understanding the lived experiences of women with inherited bleeding disorders. J Thromb Haemost. 2020;18(12):3211–3221
   PubMedGoogle Scholar
• James AH. Von Willebrand: an underdiagnosed disorder 2017 [cited 2022 May 3]. Available from: https://www.contemporaryobgyn.net/view/von-willebrand-underdiagnosed-disorde.
   Google Scholar
• Arya S, Wilton P, Page D, et al. “They don’t really take my bleeds seriously”: barriers to care for women with inherited bleeding disorders. J Thromb Haemost. 2021;19(6):1506–1514
   PubMedGoogle Scholar
• Khair K, Holland M, Pollard D. The experience of girls and young women with inherited bleeding disorders. Haemophilia. 2013;19(5):e276–81.
   PubMedGoogle Scholar
• Vázquez E, Kim M, Santaella ME. Lived experience experts: a name created by us for us, Expert Rev Hematol, 2023;16(S1):7–11. DOI: 10.1080/17474086.2023.2178410.
   Google Scholar
• Mirin AA. Gender disparity in the funding of diseases by the U.S. national institutes of health. J Womens Health (Larchmt). 2021;30(7):956–963.
   PubMed Web of Science ®Google Scholar
• Skinner MW, Nugent D, Wilton P, et al. Achieving the unimaginable: health equity in haemophilia. Haemophilia. 2020;26(1):17–24
   PubMed Web of Science ®Google Scholar
• Valentino LA, Witkop ML, Santaella ME, et al. The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary. Expert Rev Hematol. 2023;16(S1):127–132. DOI: 10.1080/17474086.2023.2181782.
   Google Scholar
• Valentino LA, Witkop ML, Santaella ME, et al. Building the blueprint: formulating a community-generated national plan for future research in inherited bleeding disorders. Haemophilia. 2022;28(5):760–768
   PubMedGoogle Scholar
• Valentino LA, Witkop ML, Santaella ME, et al. The National Hemophilia Foundation's State of the Science Research Summit initiative: the foundation of an inherited bleeding disorders national research blueprint. Expert Rev Hematol. 2023;16(S1):1–5. DOI: 10.1080/17474086.2023.2178412.
   Google Scholar
• Lillicrap D, Fijnvandraat K, Young G, et al. Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms. Expert Rev Hematol. 2020;13(4):313–321.
   PubMed Web of Science ®Google Scholar
• Sabatino DE, Pipe SW, Nugent DJ, et al. Origins and organization of the NHLBI state of the science workshop: generating a national blueprint for future research on factor VIII inhibitors. Haemophilia. 2019;25(4):575–580
   PubMedGoogle Scholar
• Tran DQ, Benson CC, Boice JA, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. Expert Rev Hematol. 2023;16(S1):19–37. DOI: 10.1080/17474086.2023.2171981.
   Google Scholar
• Sidonio RF Jr., Bryant PC, Di Paola J, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders. Expert Rev Hematol. 2023;16(S1):39–54. DOI: 10.1080/17474086.2023.2171983.
   Google Scholar
• Byams VR, Baker JR, Bailey C, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science. Expert Rev Hematol. 2023;16(S1):87–106. DOI: 10.1080/17474086.2023.2183836.
   Google Scholar
• Byams VR, Miller CH, Bethea FM, et al. Bleeding Disorders in Women and Girls: state of the Science and CDC Collaborative Programs. J Womens Health (Larchmt). 2022;31(3):301–309
   PubMedGoogle Scholar
• Kirtava A, Crudder S, Dilley A, et al. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10(2):158–161
   PubMedGoogle Scholar
• Srivaths LV, Zhang QC, Byams VR, et al. Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding. Haemophilia. 2018;24(1):63–69
   PubMedGoogle Scholar
• Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999;5(5):313–317.
   PubMedGoogle Scholar
• American Academy of Pediatrics Committee on Adolescence and American College of Obstetricians and Gynecologists Committee on Adolescent Health Care, Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006;118(5):2245–2250.
   PubMedGoogle Scholar
• Byams VR, Anderson BL, Grant AM, et al. Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists. Am J Obstet Gynecol. 2012;207(4):269 e1–5
   PubMedGoogle Scholar
• Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG COMMITTEE OPINION, Number 785. Obstet Gynecol. 2019;134(3):e71–e83
   PubMedGoogle Scholar
• James P. About Let’s Talk Period [cited Oct 4, 2022]. Available from: https://letstalkperiod.ca/about/.
   Google Scholar
• IWK Health. WeThrive: period tracking for quality of life [cited 2022 Oct 4]. Available from: https://youriwk.com/2022/06/02/we-thrive-period-tracking-for-quality-of-life/.
   Google Scholar
• Brown MC, White MH, Friedberg R, et al. Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease. Res Pract Thromb Haemost. 2021;5(4):e12513
   PubMed Web of Science ®Google Scholar
• Indiana Hemophilia & Thrombosis Center. Partners in bleeding disorders education [cited 2022 Sept 17]. Available from: https://www.partnersprn.org/.
   Google Scholar
• Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature. 2014;505(7485):612–613.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management [cited 2022 May 4]. Available from: https://www.nice.org.uk/guidance/ng88/resources/heavy-menstrual-bleeding-assessment-and-management-pdf-1837701412549.
   Google Scholar
• Magnay JL, O’Brien S, Gerlinger C, et al. A systematic review of methods to measure menstrual blood loss. BMC Womens Health. 2018;18(1):142.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Prescribing Information. Mirena (levonorgestrel-releasing intrauterine system) [cited 2022 May 4]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021225s042lbl.pdf.
   Google Scholar
• U.S. Food and Drug Administration. Prescribing Information. Natazia (estradiol valerate and estradiol valerate/dienogest) tablets, for oral use [cited 2022 May 4]. Available from: https://labeling.bayerhealthcare.com/html/products/pi/natazia_pi.pdf.
   Google Scholar
• Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest. 1964;16:244–248.
   PubMed Web of Science ®Google Scholar
• Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss–a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45(3):320–351
   PubMed Web of Science ®Google Scholar
• Magnay JL, O’Brien S, Gerlinger C, et al. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20(1):24.
   PubMed Web of Science ®Google Scholar
• Abu Hashim H, Alsherbini W, Bazeed M. Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone. Contraception. 2012;85(3):246–252.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Summary of product characteristics. Esmya 5mg tablets, INN-Ulipristal [cited 2022 May 4]. Available from: https://www.ema.europa.eu/en/documents/product-information/esmya-epar-product-information_en.pdf.
   Google Scholar
• Hoaglin DC, Filonenko A, Glickman ME, et al. Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding. Eur J Med Res. 2013;18:17.
   PubMedGoogle Scholar
• Nugent D, Acharya SS, Baumann KJ, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders. Expert Rev Hematol. 2023;16(S1):55–70. DOI: 10.1080/17474086.2023.2175661.
   Google Scholar
• Ragni MV, Young G, Batsuli G, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: Facilitating research through infrastructure, workforce, resources and funding. Expert Rev Hematol. 2023;16(S1):107–127. DOI: 10.1080/17474086.2023.2181781.
   Google Scholar
• Johns Hopkins Center for Communication Programs. Technical consultation on contraceptive-induced menstrual changes: new perspectives on research that can improve women’s lives globally [cited 2022 Jun 12]. Available from: https://knowledgesuccess.org/2021/01/20/technical-consultation-on-contraceptive-induced-menstrual-changes/.
   Google Scholar
• Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935–1939
   PubMed Web of Science ®Google Scholar